Metozolv ODT FDA Approval History
FDA Approved: Yes (Discontinued) (First approved September 4, 2009)
Brand name: Metozolv ODT
Generic name: metoclopramide
Dosage form: Orally Disintegrating Tablets
Company: Salix Pharmaceuticals, Inc.
Treatment for: GERD, Gastroparesis
Marketing Status: Discontinued
Metozolv ODT is a fast–dissolving formulation of metoclopramide for the short–term treatment of adults with gastroesophageal reflux and for the relief of symptoms associated with diabetic gastroparesis.
Development Timeline for Metozolv ODT
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.